Navigation Links
Depomed Reports Third Quarter 2013 Financial Results
Date:11/5/2013

/li>

"In the third quarter, we demonstrated significant revenue growth in both Gralise and Zipsor, and we are excited about the addition of Lazanda at the end of July," said Jim Schoeneck, President and Chief Executive Officer of Depomed. "Our recent sale of our non-core type 2 diabetes royalties, including Glumetza, to PDL BioPharma for $240.5 million gives the company significant flexibility to expand our business through acquisitions of marketed or late stage assets. With over $320 million in cash currently on our balance sheet, pending final tax considerations, and the strength of our core business in pain and neurology, we believe we are well positioned to become a leader in the central nervous system specialty pharmaceutical area."

Third Quarter 2013 Financial ResultsTotal revenues increased to $37.5 million for the third quarter of 2013, compared to $33.3 million for the third quarter of 2012 as indicated below:

 Three Months Ended September 30,20132012Product sales:Gralise$

9,812$

4,758Zipsor6,0224,926Lazanda444—Total product sales 16,2789,684Royalties:Glumetza US$

14,578$

11,603Other844598Total royalty revenue15,42212,201License and other revenue:Glumetza$

760$

1,388Janssen—10,005Mallinckrodt5,000—Other—4Total license and other revenue:5,76011,397Total revenues$

37,460$

33,282 

Selling general and administrative expense was $26.4 million for the third quarter of 2013 compared to $26.8 million for the third quarter of 2012. Third quarter 2013 expenses included two months of selling general and administrative expenses associated with Lazanda.Research and development expense was $1.3 million for the third quarter of 2013 compared to $5.3 million for the third quarter of 2012. The decrease is primarily related the Company ceasing all expenditure on Sefelsa™ during the first quarter of 2013 and the clinical trial expenses a
'/>"/>

SOURCE Depomed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
2. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
3. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
4. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
5. Depomed Reports Second Quarter 2013 Financial Results
6. Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013
7. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
8. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
9. Depomed to Present at Wells Fargo Securities 2013 Healthcare Conference
10. Depomed To Present At Jefferies 2013 Global Healthcare Conference
11. Depomed Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Calif. , Sept. 1, 2015 /PRNewswire/ ... cardiovascular image management market, Frost & Sullivan ... 2015 European Frost & Sullivan Award for ... -based PMI has designed innovative and easy-to-use ... deliver precise and reproducible quantitative results for ...
(Date:9/1/2015)... , September 1, 2015 ... company, today announces that it has appointed Hilde ... Non-Executive Directors to its Board of Directors, effective immediately. ... years of experience in pharma and biotech and is ... a Sanofi company. Previously her role was Vice President ...
(Date:9/1/2015)... 1, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... that its affiliate has entered into a collaboration ... an exclusive license to develop and commercialize brodalumab. ... monoclonal antibody in development for patients with moderate-to-severe ... Valeant will hold the exclusive rights to develop ...
Breaking Medicine Technology:Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5BerGenBio Appoints Non-Executive Directors 2Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
... Carol Keehan, DC, president and chief executive officer of ... issued the following statement. The Catholic Health ... for her intelligent and courageous decision to prevent very ... hormone contained in the drug known as Plan B. ...
... The Dr. Paul Janssen Award for Biomedical ... This prestigious award recognizes individuals whose scientific research ... significant transformational contributions toward the improvement of human ... will be accepted until February 15, 2012, for ...
Cached Medicine Technology:Catholic Health Association Applauds HHS Decision on Plan B 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 3Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 4
(Date:9/1/2015)... ... September 01, 2015 , ... ... analysis of pet vital signs and activity, today announced its integration with leading ... most popular and widely-adopted veterinary hospital Practice Management Software packages in the US. ...
(Date:9/1/2015)... MA (PRWEB) , ... September 01, 2015 , ... ... today announced the release of version 5.2 of the FirstSpirit Content Management System ... Cloud initiative. With the new version of FirstSpirit, companies will be well on ...
(Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, Inc., ... joined its medical management team as an Associate Medical Director. , WorkCare ... types in the U.S. and abroad. , Dr. Nelson has a diverse ...
(Date:9/1/2015)... San Diego, CA (PRWEB) , ... September 01, 2015 , ... ... farms are just a few of the topics to be discussed at Seedstock’s 4th ... for Nov. 3-4, 2015, at UC San Diego. , In addition to keynotes ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... is now available. With the Connectivity Kit, EasySampler data is automatically transferred ... reactor control experiment, on a touchscreen platform. , EasySampler fully automates the ...
Breaking Medicine News(10 mins):Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3
... new FDA-cleared test for vitamin D sufficiency, new, antimicrobial-susceptibility ... ... systems to screen for lead poisoning will also be on ... at the 2008,AACC/ASCLS Clinical Lab Expo will see Magellan Biosciences, ...
... temperature and,humidity rise, mold invades thousands of homes. ... mold, and invisible mold spores cause countless,allergic reactions, ... College of Allergy, Asthma and Immunology., Mold ... mold breaks,down decaying organic matter, but in a ...
... women identify any gaps in coverage or inadequate protection ... ... -- http://www.combinedinsurance.com/ [Combined Insurance], a leading provider of ... 2, 2008, sponsored by SWWAN® (Single Working Women,s Affiliate Network), ...
... Agreement with PureWellness to Provide Online Wellness Platform to All ... ... July 29, 2008 -- PureWellness, Inc, a leading provider of ... an agreement with Children,s Healthcare of Atlanta, one of the ...
... the South Carolina Department of Mental Health (SCDMH). With help ... comprehensive mental healthcare provider is advancing medical processes by moving ... ... San Francisco, CA (PRWEB) July 29, 2008 -- CoSign® digital ...
... Fast Radios, a leader in the commercial two-way radio industry, has ... for their companies. The publication, entitled "The Little Green Radio Book: ... and Care for Two Way Radios," is free and available immediately ... ...
Cached Medicine News:Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 2Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 3Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 4Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 5Health News:Creating a Healthy Home Environment: Mold and Mildew Free 2Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 2Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 3Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 4Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 5Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 2Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 3Health News:CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health 2Health News:CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health 3Health News:CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health 4Health News:Fast Radios Announces Publication of Two Way Radio Guide for Commercial Customers 2Health News:Fast Radios Announces Publication of Two Way Radio Guide for Commercial Customers 3
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... Hoffmann® II Hybrid External Fixation System ... generation in hybrid fixation. It incorporates ... and is designed to offer speed ... patented Hoffmann® snap-fit technology. , ,Using ...
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
Medicine Products: